NPPB and congestive heart failure: On the actual intervention date, 89 of 178 deferred patients (50.0%) had a plasma NT-proBNP level > 900 pg/ml, indicating CHF (control group with regular treatment time 85 of 214 patients (39.7%), (p = 0.078)).